Connection

Peter Verhamme to Drug Hypersensitivity

This is a "connection" page, showing publications Peter Verhamme has written about Drug Hypersensitivity.
Connection Strength

0.027
  1. Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. N Engl J Med. 2017 08 03; 377(5):431-441.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.